Rock Springs Capital Management LP - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2019$338,000
-13.3%
400,0000.0%0.01%
-7.1%
Q2 2019$390,000
-22.6%
400,0000.0%0.01%
-26.3%
Q1 2019$504,000
-61.1%
400,0000.0%0.02%
-68.9%
Q4 2018$1,296,000
-1.4%
400,000
-15.1%
0.06%
+19.6%
Q2 2018$1,315,000
-59.0%
471,321
-30.2%
0.05%
-62.8%
Q1 2018$3,206,000
-18.5%
675,0000.0%0.14%
-23.5%
Q4 2017$3,935,000
+316.4%
675,000
+50.0%
0.18%
+306.8%
Q3 2017$945,000
-55.1%
450,0000.0%0.04%
-58.5%
Q2 2017$2,106,000
-40.2%
450,0000.0%0.11%
-47.8%
Q1 2017$3,519,000
-36.2%
450,0000.0%0.20%
-45.0%
Q4 2016$5,517,000
-21.4%
450,0000.0%0.37%
-16.1%
Q3 2016$7,016,000
+39.4%
450,000
+8.4%
0.44%
+18.0%
Q2 2016$5,034,000
+11.1%
415,000
-11.7%
0.37%
-1.8%
Q1 2016$4,531,000470,0000.38%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 3,804,027$17,803,0002.95%
HARBOURVEST PARTNERS LLC 440,627$2,062,0000.89%
NEA Management Company, LLC 3,556,778$16,646,0000.61%
Rock Springs Capital Management LP 450,000$2,106,0000.11%
Bain Capital Public Equity Management, LLC 263,498$1,233,0000.07%
ELEMENT CAPITAL MANAGEMENT LLC 65,973$309,0000.06%
Hillhouse Capital Management 865,923$4,053,0000.06%
SABBY MANAGEMENT, LLC 125,151$586,0000.04%
Marshall Wace North America L.P. 684,124$3,421,0000.02%
FNY Partners Fund LP 20,127$94,0000.02%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders